- Home
- SOPA vs QLGN Comparison
SOPA vs QLGN Comparison
Compare SOPA & QLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPA
- QLGN
- Stock Information
- Founded
- SOPA 2018
- QLGN 1996
- Country
- SOPA Singapore
- QLGN United States
- Employees
- SOPA N/A
- QLGN N/A
- Industry
- SOPA EDP Services
- QLGN Biotechnology: Pharmaceutical Preparations
- Sector
- SOPA Technology
- QLGN Health Care
- Exchange
- SOPA Nasdaq
- QLGN Nasdaq
- Market Cap
- SOPA 3.8M
- QLGN 2.2M
- IPO Year
- SOPA 2021
- QLGN N/A
- Fundamental
- Price
- SOPA $1.26
- QLGN $3.59
- Analyst Decision
- SOPA Strong Buy
- QLGN
- Analyst Count
- SOPA 1
- QLGN 0
- Target Price
- SOPA $14.00
- QLGN N/A
- AVG Volume (30 Days)
- SOPA 1.2M
- QLGN 45.2K
- Earning Date
- SOPA 05-19-2025
- QLGN 07-01-2025
- Dividend Yield
- SOPA N/A
- QLGN N/A
- EPS Growth
- SOPA N/A
- QLGN N/A
- EPS
- SOPA N/A
- QLGN N/A
- Revenue
- SOPA $7,105,530.00
- QLGN N/A
- Revenue This Year
- SOPA $26.32
- QLGN N/A
- Revenue Next Year
- SOPA N/A
- QLGN N/A
- P/E Ratio
- SOPA N/A
- QLGN N/A
- Revenue Growth
- SOPA N/A
- QLGN N/A
- 52 Week Low
- SOPA $0.65
- QLGN $2.85
- 52 Week High
- SOPA $6.75
- QLGN $29.45
- Technical
- Relative Strength Index (RSI)
- SOPA 63.28
- QLGN 54.50
- Support Level
- SOPA $1.01
- QLGN $3.40
- Resistance Level
- SOPA $1.33
- QLGN $3.71
- Average True Range (ATR)
- SOPA 0.15
- QLGN 0.36
- MACD
- SOPA 0.06
- QLGN 0.00
- Stochastic Oscillator
- SOPA 54.50
- QLGN 36.73
About SOPA Society Pass Incorporated
Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with entrepreneurs, the company meets the growing demand for services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Corporate. The company generates the majority of its revenue from the Digital marketing segment.
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.